Economic incentives and disincentives for efficient prescribing
- PMID: 10155265
- DOI: 10.2165/00019053-199406030-00006
Economic incentives and disincentives for efficient prescribing
Abstract
Efficient prescribing is a controversial concept when defined in economic terms. Such terms imply that neither the best nor the cheapest drug may be efficient. Efficiency depends on patient evaluations of outcomes--an essential, yet still underdeveloped, field of inquiry. Encouraging prescribing efficiency (once it is clear what efficient treatments are) may require the use of incentives, (economic and otherwise). Although physicians do react to economic incentives, encouraging them to also act as good economists rather than only as good healthcare providers may be difficult since economic efficiency goals may conflict with pure medical goals. While it is conceptually reasonable to assume that economic incentives will accomplish behavioural change, other (noneconomic) incentive mechanisms may appear less controversial. Since it is the result, not the process, that is important, a mix of incentives to achieve efficient solutions is suggested. However, further investigation into both health and economic outcomes research and debate on proper efficiency goals should precede the discussion of optimal incentives.
Similar articles
-
Health plans keeping drug cost increases in check with programs that promote generics.Capitation Manag Rep. 2002 Jul;9(7):101-3, 97. Capitation Manag Rep. 2002. PMID: 12164057
-
E-prescribing adoption and use increased substantially following the start of a federal incentive program.Health Aff (Millwood). 2013 Jul;32(7):1221-7. doi: 10.1377/hlthaff.2012.1197. Health Aff (Millwood). 2013. PMID: 23836737
-
Current prescribing in primary care in the UK. Effects of the indicative prescribing scheme and GP fundholding.Pharmacoeconomics. 1995 Apr;7(4):320-31. doi: 10.2165/00019053-199507040-00006. Pharmacoeconomics. 1995. PMID: 10155321 Review.
-
Rapid prescribing change, how do patients respond?Soc Sci Med. 1996 Dec;43(11):1543-9. doi: 10.1016/s0277-9536(96)00050-0. Soc Sci Med. 1996. PMID: 8961398
-
Economic evaluation of drugs and its potential uses in policy making.Pharmacoeconomics. 1995 Sep;8(3):190-8. doi: 10.2165/00019053-199508030-00003. Pharmacoeconomics. 1995. PMID: 10172485 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources